BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33785159)

  • 1. MPA/DMBA-driven mammary carcinomas.
    Buqué A; Perez-Lanzón M; Petroni G; Humeau J; Bloy N; Yamazaki T; Sato A; Kroemer G; Galluzzi L
    Methods Cell Biol; 2021; 163():1-19. PubMed ID: 33785159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
    Buqué A; Bloy N; Perez-Lanzón M; Iribarren K; Humeau J; Pol JG; Levesque S; Mondragon L; Yamazaki T; Sato A; Aranda F; Durand S; Boissonnas A; Fucikova J; Senovilla L; Enot D; Hensler M; Kremer M; Stoll G; Hu Y; Massa C; Formenti SC; Seliger B; Elemento O; Spisek R; André F; Zitvogel L; Delaloge S; Kroemer G; Galluzzi L
    Nat Commun; 2020 Jul; 11(1):3819. PubMed ID: 32732875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations.
    Abba MC; Zhong Y; Lee J; Kil H; Lu Y; Takata Y; Simper MS; Gaddis S; Shen J; Aldaz CM
    Oncotarget; 2016 Sep; 7(39):64289-64299. PubMed ID: 27588403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by 9alpha-fluoromedoroxyprogesterone acetate (FMPA) against mammary carcinoma induced by dimethylbenz[a]anthracene in rats and angiogenesis in the rabbit cornea - comparison with medroxyprogesterone acetate (MPA).
    Uchida M; Tsuboi H; Yamaji T; Murata N; Kohno T; Sugino E; Hibino S; Shimamura M; Oikawa T
    Cancer Lett; 2000 Jun; 154(1):63-9. PubMed ID: 10799740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of medroxyprogesterone acetate on DMBA-induced rat mammary carcinoma and on immunological reactivity.
    Spreafico F; Filippeschi S; Malfiore C; Noseda S; Falautano P; Serraglia N
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):45-51. PubMed ID: 6211360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
    Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
    Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
    Dauvois S; Spinola PG; Labrie F
    Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen.
    Mansour A; Daba A; Baddour N; El-Saadani M; Aleem E
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1579-96. PubMed ID: 22552717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.
    Aldaz CM; Liao QY; LaBate M; Johnston DA
    Carcinogenesis; 1996 Sep; 17(9):2069-72. PubMed ID: 8824536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN/PIK3CA genes are frequently mutated in spontaneous and medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumours of tree shrews.
    Xia HJ; He BL; Wang CY; Zhang HL; Ge GZ; Zhang YX; Lv LB; Jiao JL; Chen C
    Eur J Cancer; 2014 Dec; 50(18):3230-42. PubMed ID: 25457635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
    Benakanakere I; Besch-Williford C; Carroll CE; Hyder SM
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1157-67. PubMed ID: 20699413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular senescence in the response of HR
    Klapp V; Buqué A; Bloy N; Sato A; Yamazaki T; Zhou XK; Formenti SC; Galluzzi L; Petroni G
    J Transl Med; 2023 Feb; 21(1):110. PubMed ID: 36765430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Carroll CE; Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
    Menopause; 2010; 17(1):178-84. PubMed ID: 19629015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Li S; Lévesque C; Geng CS; Yan X; Labrie F
    Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
    Iino Y; Ishikawa H; Izuo M; Takikawa H
    Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human breast adenocarcinoma cytotoxicity and modulation of 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma in Balb/c mice by Acacia catechu (L.f.) Wild heartwood.
    Monga J; Chauhan CS; Sharma M
    Integr Cancer Ther; 2013 Jul; 12(4):347-62. PubMed ID: 23142797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
    Ishikawa H; Iino Y; Izuo M; Takikawa H
    Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.
    Oikawa T; Hiragun A; Yoshida Y; Ashino-Fuse H; Tominaga T; Iwaguchi T
    Cancer Lett; 1988 Dec; 43(1-2):85-92. PubMed ID: 2462464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of modeling effects of two different 7, 12-dimethylbenz[a] anthracene induced breast cancer models in tree shrew].
    Mao AY; Chen MJ; Yang C; Ou C; Ye XQ; Qin QH; Mo M; Wei CY
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):346-350. PubMed ID: 31137167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.